Bos JM - Search Results

1

Enhanced decision support for policy makers using a web interface to health-economic models--illustrated with a cost-effectiveness analysis of nation-wide infant vaccination with the 7-valent pneumococcal conjugate vaccine in the Netherlands.

Hubben GA, Bos JM, Glynn DM, van der Ende A, van Alphen L, Postma MJ. Hubben GA, et al. Among authors: bos jm. Vaccine. 2007 May 4;25(18):3669-78. doi: 10.1016/j.vaccine.2007.01.088. Epub 2007 Feb 5. Vaccine. 2007. PMID: 17360082

2

Economic evaluation of meningococcal serogroup C conjugate vaccination programmes in The Netherlands and its impact on decision-making.

Welte R, van den Dobbelsteen G, Bos JM, de Melker H, van Alphen L, Spanjaard L, Rümke HC, Postma MJ. Welte R, et al. Among authors: bos jm. Vaccine. 2004 Dec 9;23(4):470-9. doi: 10.1016/j.vaccine.2004.06.019. Vaccine. 2004. PMID: 15530695

3

The societal burden of HIV/AIDS in Northern Italy: an analysis of costs and quality of life.

Hubben GA, Bishai D, Pechlivanoglou P, Cattelan AM, Grisetti R, Facchin C, Compostella FA, Bos JM, Postma MJ, Tramarin A. Hubben GA, et al. Among authors: bos jm. AIDS Care. 2008 Apr;20(4):449-55. doi: 10.1080/09540120701867107. AIDS Care. 2008. PMID: 18449822

4

Discounting health effects in pharmacoeconomic evaluations: current controversies.

Bos JM, Postma MJ, Annemans L. Bos JM, et al. Pharmacoeconomics. 2005;23(7):639-49. doi: 10.2165/00019053-200523070-00001. Pharmacoeconomics. 2005. PMID: 16173156

5

The use of health economics to guide drug development decisions: Determining optimal values for an RSV-vaccine in a model-based scenario-analytic approach.

Bos JM, Rietveld E, Moll HA, Steyerberg EW, Luytjes W, Wilschut JC, de Groot R, Postma MJ. Bos JM, et al. Vaccine. 2007 Sep 28;25(39-40):6922-9. doi: 10.1016/j.vaccine.2007.07.006. Epub 2007 Jul 30. Vaccine. 2007. PMID: 17707959

6

Do costs of varicella justify routine infant vaccination? Pharmacoeconomic and clinical considerations.

Postma MJ, Bos JM, Welte R, de Groot R, Luytjes W, Rümke HC, Beutels P. Postma MJ, et al. Among authors: bos jm. Eur J Health Econ. 2004 Feb;5(1):54-7. doi: 10.1007/s10198-003-0201-6. Eur J Health Econ. 2004. PMID: 15452765 No abstract available.

7

Pharmaco-economic evaluation of targeted hepatitis A vaccination for children of ethnic minorities in Amsterdam (The Netherlands).

Postma MJ, Bos JM, Beutels P, Schilthuis H, van den Hoek JA. Postma MJ, et al. Among authors: bos jm. Vaccine. 2004 May 7;22(15-16):1862-7. doi: 10.1016/j.vaccine.2003.11.012. Vaccine. 2004. PMID: 15121296

8

The economics of HIV vaccines: projecting the impact of HIV vaccination of infants in sub-Saharan Africa.

Bos JM, Postma MJ. Bos JM, et al. Pharmacoeconomics. 2001;19(9):937-46. doi: 10.2165/00019053-200119090-00005. Pharmacoeconomics. 2001. PMID: 11700780 Review.

9

Cost-effectiveness of HIV screening of patients attending clinics for sexually transmitted diseases in Amsterdam.

Bos JM, Fennema JS, Postma MJ. Bos JM, et al. AIDS. 2001 Oct 19;15(15):2031-6. doi: 10.1097/00002030-200110190-00017. AIDS. 2001. PMID: 11600833

10

Economic evaluation of influenza vaccination. Assessment for The Netherlands.

Postma MJ, Bos JM, van Gennep M, Jager JC, Baltussen R, Sprenger MJ. Postma MJ, et al. Among authors: bos jm. Pharmacoeconomics. 1999;16 Suppl 1:33-40. doi: 10.2165/00019053-199916001-00005. Pharmacoeconomics. 1999. PMID: 10623374 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results